Loss of IκBα-mediated control over nuclear import and DNA binding enables oncogenic activation of c-Rel

Molecular and Cellular Biology

Volumn 18, Issue 9, 1998, Pages 5445-5456

  Sachdev, Shrikesh ^a   Hannink, Mark ^a  

^a University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL NUCLEUS; CELL TRANSFORMATION; CONTROLLED STUDY; GENE ACTIVATION; GENE STRUCTURE; INTRACELLULAR TRANSPORT; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; TRANSCRIPTION REGULATION; AMINO ACID SEQUENCE; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL STRAIN COS1; CHEMISTRY; CHICK EMBRYO; DRUG ANTAGONISM; FIBROBLAST; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC TRANSFECTION; KINETICS; METABOLISM; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY;

ANIMALIA;

DNA BINDING PROTEIN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; ONCOPROTEIN; RECOMBINANT PROTEIN; TRANSCRIPTION FACTOR REL;

AMINO ACID SEQUENCE; ANIMALS; CELL NUCLEUS; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CHICK EMBRYO; COS CELLS; DNA-BINDING PROTEINS; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; I-KAPPA B PROTEINS; KINETICS; NF-KAPPA B; ONCOGENE PROTEINS V-REL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-REL; RECOMBINANT PROTEINS; RETROVIRIDAE PROTEINS, ONCOGENIC; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; TRANSFECTION;

EID: 0031594844     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.18.9.5445     Document Type: Article

References (62)

1. Alkalay, I., A. Yaron, A. Hatzubai, A. Orian, A. Ciechanover, and Y. Ben-Neriah. 1995. Stimulation-dependent IκBα phosphorylation marks the NF-κB inhibitor for degradation via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA 92:10599-10603.
2. Arenzana-Seisdedos, F., J. Thompson, M. S. Rodriguez, F. Bachelerie, D. Thomas, and R. T. Hay. 1995. Inducible nuclear expression of newly synthesized IκBα negatively regulates DNA-binding and transcription al activities of NF-κB Mol. Cell. Biol. 15:2689-2696.
3. Arenzana-Seisdedos, F., P. Turpin, M. Rodriguez, D. Thomas, R. T. Hay, J. L. Virelizier, and C. Dargemont. 1997. Nuclear localization of IκBα promotes active transport of NF-κB from the nucleus to the cytoplasm. J. Cell Sci. 110:369-378.
4. Baldwin, A. S., Jr. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649-683.
5. Beg, A. A., S. M. Ruben, R. I. Scheinman, S. Haskill, C. A. Rosen, and A. S. Baldwin, Jr. 1992. IκB interacts with the nuclear localization sequences of the subunits of NF-κB: a mechanism for cytoplasmic retention. Genes Dev. 6:1899-1913.
6. Brockman, J. A., D. C. Scherer, T. A. McKinsey, S. M. Hall, X. Qi, W. Y. Lee, and D. W. Ballard. 1995. Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation. Mol. Cell. Biol. 15:2809-2816.
7. c-rel is a cytoplasmic protein in chicken embryo fibroblasts. Oncogene 5:257-266.
8. Carrasco, D., P. Perez, A. Lewin, and R. Bravo. 1997. IκBα overexpression delays tumor formation in v-rel transgenic mice. J. Exp. Med. 186:279-288.
9. Carrasco, D., C. A. Rizzo, K. Dorfman, and R. Bravo. 1996. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice. EMBO J. 15:3640-3650.
10. Chang, C. C., J. Zhang, L. Lombardi, A. Neri, and R. Dalla-Favera. 1995. Rearranged NFKB-2 genes in lymphoid neoplasms code for constitutively active nuclear transactivators. Mol. Cell. Biol. 15:5180-5187.
11. Chen, Z., J. Hagler, V. J. Palombella, F. Melandri, D. Scherer, D. Ballard, and T. Maniatis. 1995. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev. 9:1586-1597.
12. Cressman, D. E., and R. Taub. 1993. IκBα can localize in the nucleus but shows no direct transactivation potential. Oncogene 8:2567-2573.
13. v-rel complexes. J. Virol. 64:584-591.
14. Davis, N., S. Ghosh, D. L. Simmons, P. Tempst, H. C. Liou, D. Baltimore, and H. R. Bose, Jr. 1991. ref-associated pp40: an inhibitor of the rel family of transcription factors. Science 253:1268-1271.
15. DiDonato, J. A., M. Hayakawa, D. M. Rothwarf, E. Zandi, and M. Karin. 1997. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature (London) 388:548-554.
16. I&B-β 3 inhibition of DNA binding by rel proteins. Mol. Cell. Biol. 13:1769-1778.
17. Diehl, J. A., W. Tong, G. Sun, and M. Hannink, 1995. TNF-α-dependent activation of a RelA homodimer in astrocytes: increased phosphorylation of RelA and MAD-3 precede activation of RelA. J. Biol. Chem. 270:2703-2707.
18. Dougherty, J. P., and H. M. Temin. 1986. High mutation rate of a spleen necrosis virus-based retrovirus vector. Mol. Cell. Biol. 6:4387-4395.
19. Finco, T. S-, J. K. Westwick, J. L. Norris, A. A. Beg, C. J. Der, and A. S. Baldwin, Jr. 1997. Oncogenic Ha-Ras-induced signaling activates NF-κB transcriptional activity, which is required for cellular transformation. J. Biol. Chem. 272:24113-24116.
20. Fischer, U., J. Huber, W. C. Boelens, I. W. Mattaj, and R. Luhrmann. 1995. The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell 82:475-483.
21. Fornerod, M., M. Ohno, M. Yoshida, and I. W. Mattaj. 1997. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 90:1051-1060.
22. Fukuda, M., S. Asano, T. Nakamura, M. Adachi, M. Yoshida, M. Yanagida, and E. Nishida. 1997. CRM1 is responsible for intracellular transport mediated by the nuclear export signal. Nature (London) 390:308-311.
23. Ganchi, P. A., S. C. Sun, W. C. Greene, and D. W. Ballard. 1992. IκB/MAD-3 masks the nuclear localization signal of NF-κB p65 and requires the transactivation domain to inhibit NF-κB p65 DNA binding. Mol. Biol. Cell 3:1339-1352.
24. Ghattas, I. R., J. R. Sanes, and J. E. Majors. 1991, The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos. Mol. Cell. Biol. 11:5848-5859.
25. Gilmore, T. D., and H. M. Temin. 1986. Different localization of the product of the v-rel oncogene in chicken fibroblasts and spleen cells correlates with transformation by REV-T. Cell 44:791-800.
26. Gilmore, T. D., M. Koedood, K. A. Piffat, and D. W. White. 1996. Rel/NF-κB/IκB proteins and cancer. Oncogene 13:1367-1378.
27. Görlich, D., and I. W. Mattaj. 1996. Nucleocytoplasmic transport. Science 271:1513-1518.
28. Hrdlickova, R., J. Nehyba, and E. H. Humphries. 1994. In vivo evolution of c-rel oncogenic potential. J. Virol. 68:2371-2382.
29. Hrdlickova, R., J. Nehyba, and H. R. Bose, Jr. 1995. Mutations in the DNA-binding and dimerization domains of v-Rel are responsible for altered κB DNA-binding complexes in transformed cells. J. Virol. 69:3369-3380.
30. Hrdlickova, R., J. Nehyba, A. Roy, E. H. Humphries, and H. R. Bose, Jr. 1995. The relocalization of v-Rel from the nucleus to the cytoplasm coincides with induction of expression of Ikba and nfkb1 and stabilization of IκB-α. J. Virol. 69:403-413.
31. Ito, C. Y., A. G. Kazantsev, and A. S. Baldwin, Jr. 1994. Three NF-κB sites in the IκB-α promoter are required for induction of gene expression by TNF-α. Nucleic Acids Res. 22:3787-3792.
32. Le Bail, O., R. Schmidt-Ullrich, and A. Israel. 1993. Promoter analysis of the gene encoding the I κBα/MAD-3 inhibitor of NF-κB: positive regulation by members of the Rel/NF-κB family. EMBO J. 12:5043-5049.
33. Mayo, M. W., C.-Y. Wang, P. C. Cogswell, K. S. Rogers-Graham, S. W. Lowe, C. J. Der, and A. S. Baldwin, Jr. 1998. Requirement of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science 278: 1812-1815.
34. Mercurio, F., H. Zhu, B. W. Murray, A. Shevchenko, B. L. Bennett, J. Li, D. B. Young, M. Barbosa, M. Mann, A. Manning, and A. Rao. 1997. IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science 278:860-866.
35. Michael, W. M., M. Choi, and G. Dreyfuss. 1995. A nuclear export signal in hnRNP A1: a signal-mediated temperature-dependent nuclear protein export pathway. Cell 83:415-422.
36. Morin, P. J., and T. D. Gilmore. 1992. The C-terminus of the NF-κB p50 precursor and an IκB isoform contain transcription activation domains. Nucleic Acids Res. 20:2453-2458.
37. Nehyba, J., R. Hrdlickova, and H. R. Bose, Jr. 1997. Differences in κB DNA-binding properties of v-Rel and c-Rel are the result of oncogenic mutations in three distinct functional regions of the Rel protein, Oncogene 14:2881-2897.
38. Nigg, E. A. 1997. Nucleocytoplasmic transport: signals, mechanisms and regulation. Nature (London) 386:779-787.
39. Nishi, K., M. Yoshida, D. Fujiwara, M. Nishikawa, S. Horinouchi, and T. Beppu. 1994. Leptomycin B targets a regulatory cascade of crm1 a fission yeast nuclear protein, involved in control of higher order chromosome structure and gene expression. J. Biol. Chem. 269:6320-6324.
40. Ossareh-Nazari, B., F. Bachelerie, and C. Dargemont. 1997. Evidence for a role of CRM1 in signal-mediated nuclear protein export. Science 278:141-144.
41. Regnier, C. H., H. Y. Song, X. Gao, D. V. Goeddel, Z. Cao, and M. Rothe. 1997. Identification and characterization of an IκB kinase. Cell 90:373-383.
42. Richardson, P. M., and T. D. Gilmore. 1991. v-Rel is an inactive member of the Rel family of transcriptional activating proteins. J. Virol. 65:3122-3130.
43. Rottjakob, E. M., S. Sachdev, C. A. Leanna, T. A. McKinsey, and M. Hannink. 1996. PEST-dependent cytoplasmic retention of v-Rel by IκB-α: evidence that IκB-α regulates cellular localization of c-Rel and v-Rel by distinct mechanisms. J. Virol. 70:3176-3188.
44. Sachdev, S., E. M. Rottjakob, J. A. Diehl, and M. Hannink. 1995. IκB-κmediated inhibition of nuclear transport and DNA-binding by Rel proteins are separable functions: phosphorylation of C-terminal serine residues of Iκ-α is specifically required for inhibition of DNA-binding. Oncogene 11: 811-823.
45. Sachdev, S., J. A. Diehl, T. A. McKinsey, A. Hans, and M. Hannink. 1997. A threshold nuclear level of the v-Rel oncoprotein is required for transformation of avian lymphocytes. Oncogene 14:2585-2594.
46. Sachdev, S., A. Hoffmann, and M. Hannink. 1998. Nuclear localization of IκBα is mediated by the second ankyrin repeat: the IκBα ankyrin repeats define a novel class of cis-acting nuclear import sequences. Mol. Cell. Biol. 18:2524-2534.
47. Sachdev, S., and M. Hannink. Unpublished data.
48. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
49. Schatzle, J. D., J. Kralova, and H. R. Bose, Jr. 1995. Avian IκBα is transcriptionally induced by c-Rel and v-Rel with different kinetics. J. Virol. 69:5383-5390.
50. Scherer, D. C., J. A. Brockman, Z. Chen, T. Maniatis, and D. W. Ballard. 1995. Signal-induced degradation of IκBα requires site-specific ubiquitination. Proc. Natl. Acad. Sci. USA 92:11259-11263.
51. Simek, S. L., R. M. Stephens, and N. R. Rice. 1986. Localization of the v-rel protein in reticuloendotheliosis virus strain T-transformed lymphoid cells. J. Virol. 59:120-126.
52. Stade, K., C. S. Ford, C. Guthrie, and K. Weis. 1997. Exportin l (Crm1p) is an essential nuclear export factor. Cell 90:1041-1050.
53. Sun, S. C., P. A. Ganchi, D. W. Ballard, and W. C. Greene. 1993. NF-θB controls expression of inhibitor κBα: evidence for an inducible autoregulatory pathway. Science 259:1912-1915.
54. Sylla, B. S., and H. M. Temin. 1986. Activation of oncogenicity of the c-rel proto-oncogcne. Mol. Cell. Biol. 6:4709-4716.
55. Traenckner, E. B., H. L. Pahl, T. Henkel, K. N. Schmidt, S. Wilk, and P.A. Baeuerle. 1995. Phosphorylation of human IκB-α on serines 32 and 36 controls IκB-α proteolysis and NF-κB activation in response to diverse stimuli. EMBO J. 14:2876-2883.
56. Tran, K., M. Merika, and D. Thanos. 1997. Distinct functional properties of IκBα and IκBβ. Mol. Cell. Biol. 17:5386-5399.
57. Wen, W., J. L. Meinkoth, R. Y. Tsien, and S. S. Taylor. 1995. Identification of a signal for rapid export of proteins from the nucleus. Cell 82:463-473.
58. Wilhelmsen, K. C., K. Eggleton, and H. M. Temin. 1984. Nucleic acid sequences of the oncogene v-rel in reticuloendotheliosis virus strains T and its cellular homolog, the proto-oncogene c-rel. J. Virol. 52:172-182.
59. Woronicz, J. D., X. Gao, Z. Cao, M. Rothe, and D. V. Goeddel. 1997 IκB kinase-β: NF-κB activation and complex formation with IκB kinase-α and NIK. Science 278:866-869.
60. Yaron, A., H. Gonen, I. Alkalay, A. Hatzubai, S. Jung, S. Beyth, F. Mercurio, A. M. Manning, A. Ciechanover, and Y. Ben-Neriah. 1997. Inhibition of NF-κB cellular function via specific targeting of the IκB-ubiquitin ligase. EMBO J. 16:6486-6494.
61. Zabel, U., T. Henkel, M. S. Silva, and P. A. Baeuerle. 1993. Nuclear uptake control of NF-κB by MAD-3, an IκB protein present in the nucleus. EMBO J. 12:201-211.
62. Zandi, E., D. M. Rothwarf, M. Delhase, M. Hayakawa, and M. Karin. 1997. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ. necessary for IκB phosphorylation and NF-κB activation. Cell 91: 243-252.